fromNature2 days agoMedicineHope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection
fromNature2 days agoMedicineHope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection
MedicinefromMedCity News1 week agoEuropean Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option - MedCity NewsEuropean approval permits ExCellThera's UM171 (Zemcelpro) cord‑blood‑derived cell therapy as an allogeneic stem cell transplant option for adults lacking matched donors.
PhilosophyfromMedCity News1 month agoThe Myth of All-American Drugs and What Trump's Tariffs Miss About Pharma Supply Chains - MedCity NewsNkarta's cell therapies face potential impact from pharmaceutical tariffs affecting supply chain costs and availability of key materials.
US newsfromNature2 months agoUS-China trade conflict threatens biomedical collaborationUS-China trade conflict hampers biomedical research in China, delaying projects and increasing costs.
Bayern Munichfromwww.berkeleyside.org2 months agoGoing green: Bayer's newest Berkeley facility earns LEED platinumBayer's new facility in Berkeley received LEED Platinum certification and the Facility of the Year Award for its advancement in sustainable pharmaceutical manufacturing.
CancerfromNature3 months agoHow CAR-T cancer therapies could harm the brainCell therapies for cancer can trigger harmful immune responses affecting the brain.Study results in mice may inform safer cancer treatment strategies in humans.